275 related articles for article (PubMed ID: 25690005)
1. Cognitive Behavioral Therapy Versus Sertraline in Patients With Depression and Poorly Controlled Diabetes: The Diabetes and Depression (DAD) Study: A Randomized Controlled Multicenter Trial.
Petrak F; Herpertz S; Albus C; Hermanns N; Hiemke C; Hiller W; Kronfeld K; Kruse J; Kulzer B; Ruckes C; Zahn D; Müller MJ
Diabetes Care; 2015 May; 38(5):767-75. PubMed ID: 25690005
[TBL] [Abstract][Full Text] [Related]
2. Study protocol of the Diabetes and Depression Study (DAD): a multi-center randomized controlled trial to compare the efficacy of a diabetes-specific cognitive behavioral group therapy versus sertraline in patients with major depression and poorly controlled diabetes mellitus.
Petrak F; Herpertz S; Albus C; Hermanns N; Hiemke C; Hiller W; Kronfeld K; Kruse J; Kulzer B; Ruckes C; Müller MJ
BMC Psychiatry; 2013 Aug; 13():206. PubMed ID: 23915015
[TBL] [Abstract][Full Text] [Related]
3. Program ACTIVE II: Outcomes From a Randomized, Multistate Community-Based Depression Treatment for Rural and Urban Adults With Type 2 Diabetes.
de Groot M; Shubrook JH; Hornsby WG; Pillay Y; Mather KJ; Fitzpatrick K; Yang Z; Saha C
Diabetes Care; 2019 Jul; 42(7):1185-1193. PubMed ID: 31221693
[TBL] [Abstract][Full Text] [Related]
4. Web-Based Cognitive Behavioral Therapy Blended With Face-to-Face Sessions for Major Depression: Randomized Controlled Trial.
Nakao S; Nakagawa A; Oguchi Y; Mitsuda D; Kato N; Nakagawa Y; Tamura N; Kudo Y; Abe T; Hiyama M; Iwashita S; Ono Y; Mimura M
J Med Internet Res; 2018 Sep; 20(9):e10743. PubMed ID: 30249583
[TBL] [Abstract][Full Text] [Related]
5. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 diabetes.
Safren SA; Gonzalez JS; Wexler DJ; Psaros C; Delahanty LM; Blashill AJ; Margolina AI; Cagliero E
Diabetes Care; 2014; 37(3):625-33. PubMed ID: 24170758
[TBL] [Abstract][Full Text] [Related]
7. Glycemic control improvement through treatment of depression using antidepressant drugs in patients with diabetes mellitus type 1.
Komorousova J; Beran J; Rusavy Z; Jankovec Z
Neuro Endocrinol Lett; 2010; 31(6):801-6. PubMed ID: 21196929
[TBL] [Abstract][Full Text] [Related]
8. Reduction of depressive symptoms predicts improved glycaemic control: Secondary results from the DIAMOS study.
Schmitt A; Reimer A; Ehrmann D; Kulzer B; Haak T; Hermanns N
J Diabetes Complications; 2017 Nov; 31(11):1608-1613. PubMed ID: 28865713
[TBL] [Abstract][Full Text] [Related]
9. Treatment of atypical depression: post-hoc analysis of a randomized controlled study testing the efficacy of sertraline and cognitive behavioural therapy in mildly depressed outpatients.
Henkel V; Mergl R; Allgaier AK; Hautzinger M; Kohnen R; Coyne JC; Möller HJ; Hegerl U
Eur Psychiatry; 2010 Dec; 25(8):491-8. PubMed ID: 20965118
[TBL] [Abstract][Full Text] [Related]
10. One-year follow-up of a randomized controlled trial of sertraline and cognitive behavior group therapy in depressed primary care patients (MIND study).
Mergl R; Allgaier AK; Hautzinger M; Coyne JC; Hegerl U; Henkel V
J Affect Disord; 2018 Apr; 230():15-21. PubMed ID: 29355727
[TBL] [Abstract][Full Text] [Related]
11. Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial.
Lustman PJ; Clouse RE; Nix BD; Freedland KE; Rubin EH; McGill JB; Williams MM; Gelenberg AJ; Ciechanowski PS; Hirsch IB
Arch Gen Psychiatry; 2006 May; 63(5):521-9. PubMed ID: 16651509
[TBL] [Abstract][Full Text] [Related]
12. Impact of sertraline on weight, waist circumference and glycemic control: A prospective clinical trial on depressive diabetic type 2 patients.
Rachdi C; Damak R; Fekih Romdhane F; Ouertani H; Cheour M
Prim Care Diabetes; 2019 Feb; 13(1):57-62. PubMed ID: 30287230
[TBL] [Abstract][Full Text] [Related]
13. A randomised controlled trial of cognitive behaviour therapy and motivational interviewing for people with Type 1 diabetes mellitus with persistent sub-optimal glycaemic control: a Diabetes and Psychological Therapies (ADaPT) study.
Ismail K; Maissi E; Thomas S; Chalder T; Schmidt U; Bartlett J; Patel A; Dickens C; Creed F; Treasure J
Health Technol Assess; 2010 May; 14(22):1-101, iii-iv. PubMed ID: 20483060
[TBL] [Abstract][Full Text] [Related]
14. Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial.
Moak DH; Anton RF; Latham PK; Voronin KE; Waid RL; Durazo-Arvizu R
J Clin Psychopharmacol; 2003 Dec; 23(6):553-62. PubMed ID: 14624185
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of cognitive behavioural therapy augmentation in major depression treatment (ECAM study): study protocol for a randomised clinical trial.
Nakagawa A; Sado M; Mitsuda D; Fujisawa D; Kikuchi T; Abe T; Sato Y; Iwashita S; Mimura M; Ono Y
BMJ Open; 2014 Oct; 4(10):e006359. PubMed ID: 25335963
[TBL] [Abstract][Full Text] [Related]
16. Manualised cognitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCT.
Serfaty M; King M; Nazareth I; Moorey S; Aspden T; Tookman A; Mannix K; Gola A; Davis S; Wood J; Jones L
Health Technol Assess; 2019 May; 23(19):1-106. PubMed ID: 31097078
[TBL] [Abstract][Full Text] [Related]
17. A comparison of cognitive-behavioral therapy, sertraline, and their combination for adolescent depression.
Melvin GA; Tonge BJ; King NJ; Heyne D; Gordon MS; Klimkeit E
J Am Acad Child Adolesc Psychiatry; 2006 Oct; 45(10):1151-1161. PubMed ID: 17003660
[TBL] [Abstract][Full Text] [Related]
18. Cognitive behavioural therapy (CBT) compared with blood glucose awareness training (BGAT) in poorly controlled Type 1 diabetic patients: long-term effects on HbA moderated by depression. A randomized controlled trial.
Snoek FJ; van der Ven NC; Twisk JW; Hogenelst MH; Tromp-Wever AM; van der Ploeg HM; Heine RJ
Diabet Med; 2008 Nov; 25(11):1337-42. PubMed ID: 19046225
[TBL] [Abstract][Full Text] [Related]
19. Are treatment preferences relevant in response to serotonergic antidepressants and cognitive-behavioral therapy in depressed primary care patients? Results from a randomized controlled trial including a patients' choice arm.
Mergl R; Henkel V; Allgaier AK; Kramer D; Hautzinger M; Kohnen R; Coyne J; Hegerl U
Psychother Psychosom; 2011; 80(1):39-47. PubMed ID: 20975325
[TBL] [Abstract][Full Text] [Related]
20. Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression.
Tadić A; Helmreich I; Mergl R; Hautzinger M; Kohnen R; Henkel V; Hegerl U
J Affect Disord; 2010 Jan; 120(1-3):86-93. PubMed ID: 19428118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
